JGUA
CELG

John G. Ullman & Associates’s Celgene Corp CELG Stock Holding History

John G. Ullman & Associates’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-4,908
Closed -$454K – 161
2019
Q2 		$454K Hold
4,908
– – 0.08% 98
2019
Q1 		$463K Sell
4,908
-100
-2% -$8.75K 0.08% 89
2018
Q4 		$321K Sell
5,008
-600
-11% -$44.3K 0.06% 104
2018
Q3 		$502K Buy
5,608
+400
+8% +$35.3K 0.09% 87
2018
Q2 		$414K Buy
5,208
+1,200
+30% +$99.6K 0.08% 87
2018
Q1 		$358K Hold
4,008
– – 0.07% 93
2017
Q4 		$418K Hold
4,008
– – 0.08% 90
2017
Q3 		$584K Hold
4,008
– – 0.11% 77
2017
Q2 		$521K Hold
4,008
– – 0.1% 85
2017
Q1 		$499K Buy
+4,008
New +$480K 0.1% 90

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

John G. Ullman & Associates's CELG Position: Q3 2019 in Review

John G. Ullman & Associates sold out of Celgene Corp (CELG) in Q3 2019, closing a stake of 4,908 shares — an estimated $454K sold.

John G. Ullman & Associates first reported a position in CELG in Q1 2017 and held it in 10 quarters. The position peaked at $584K in Q3 2017. 1,245 funds tracked by Wall St. Rank hold CELG as of Q3 2019.

  • John G. Ullman & Associates reported no remaining Celgene Corp position as of Q3 2019 after selling out during the quarter.
  • John G. Ullman & Associates sold 4,908 Celgene Corp shares in Q3 2019, an estimated $454K.
  • John G. Ullman & Associates first reported a position in Celgene Corp in Q1 2017 and held it in 10 quarters.
  • John G. Ullman & Associates's Celgene Corp position peaked at $584K in Q3 2017.
  • 1,245 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2019.

Based on John G. Ullman & Associates's 13F filing for Q3 2019, filed 21 Oct 2019.